TY - JOUR
T1 - Pathophysiological Reconstruction of a Tissue-Specific Multiple-Organ On-A-Chip for Type 2 Diabetes Emulation using 3D Cell Printing
AU - Kim, Joeng Ju
AU - Park, Ju Young
AU - Nguyen, Vy Vuong Tuong
AU - Bae, Mihyeon
AU - Kim, Myungji
AU - Jang, Jinah
AU - Won, Jae Yon
AU - Cho, Dong Woo
N1 - Publisher Copyright:
© 2023 Wiley-VCH GmbH.
PY - 2023/5/25
Y1 - 2023/5/25
N2 - Type 2 diabetes mellitus (T2D), a chronic complex disease with high prevalence, causes severe damage to various organs. T2D has many etiologies that have not been fully elucidated. Although various models have been created to understand T2D, reconstructing the tissue-specific microenvironment and complications of T2D remain difficult. Therefore, a dynamic multiple-organ on-a-chip that mimics T2D in a hyperglycemic environment and visceral adipose tissue (vAT) using 3D cell printing with decellularized extracellular matrix (dECM) bioinks is developed. This chip composed of separate compartments for the pancreas, adipose tissue, and liver, closely related to T2D, and a retinal compartment is added to confirm T2D complications. Furthermore, the pathological features of T2D are clearly revealed in the chip with vAT-derived dECM bioink in a hyperglycemic environment. These pathological features caused cellular dysfunctions of the retinal compartment. Moreover, treated T2D medications on the chip showed clinically identical efficacy. The chip is suitable for recapitulating the key features of T2D and is a promising platform for drug testing and T2D complication research.
AB - Type 2 diabetes mellitus (T2D), a chronic complex disease with high prevalence, causes severe damage to various organs. T2D has many etiologies that have not been fully elucidated. Although various models have been created to understand T2D, reconstructing the tissue-specific microenvironment and complications of T2D remain difficult. Therefore, a dynamic multiple-organ on-a-chip that mimics T2D in a hyperglycemic environment and visceral adipose tissue (vAT) using 3D cell printing with decellularized extracellular matrix (dECM) bioinks is developed. This chip composed of separate compartments for the pancreas, adipose tissue, and liver, closely related to T2D, and a retinal compartment is added to confirm T2D complications. Furthermore, the pathological features of T2D are clearly revealed in the chip with vAT-derived dECM bioink in a hyperglycemic environment. These pathological features caused cellular dysfunctions of the retinal compartment. Moreover, treated T2D medications on the chip showed clinically identical efficacy. The chip is suitable for recapitulating the key features of T2D and is a promising platform for drug testing and T2D complication research.
KW - 3D cell printing
KW - decellularized extracellular matrix bioinks
KW - disease in vitro models
KW - drug test platforms
KW - multiple-organs on-a-chip
KW - type 2 diabetes
KW - visceral adipose tissue
UR - https://www.scopus.com/pages/publications/85150490855
U2 - 10.1002/adfm.202213649
DO - 10.1002/adfm.202213649
M3 - Article
AN - SCOPUS:85150490855
SN - 1616-301X
VL - 33
JO - Advanced Functional Materials
JF - Advanced Functional Materials
IS - 22
M1 - 2213649
ER -